Target intelligence / Profile preview

SET pseudogene 11 (SETP11)

Target
SETP11
Molecular classification
Pseudogene, Non-coding RNA gene (potentially), Other
01

Overview

SET pseudogene 11 (SETP11) is a genomic DNA sequence similar to the SET nuclear proto-oncogene but is predicted to be a nonfunctional pseudogene[3][4]. Pseudogenes are typically derived from duplication or retrotransposition events and harbor mutations that disrupt their protein-coding capacity, making them incapable of expressing functional proteins[2][4]. While some pseudogenes have been shown to regulate gene expression via noncoding RNA mechanisms such as microRNA sponging, antisense RNA, or long non-coding RNAs, there is no current evidence or literature suggesting SETP11 has any functional, diagnostic, or therapeutic relevance[3][5][6]. Overall, SETP11 is not considered a classical therapeutic target, and its designation as such is likely a misinterpretation or error. For structured data extraction or ontological mapping, SETP11 should be listed as a pseudogene, not a target. It lacks relevance as a protein, receptor, enzyme, or transporter, and has no documented involvement in disease or therapeutic contexts.

Other names
SETP11SET nuclear oncogene pseudogene
02

Biological functions

Regulatory non-coding RNA function (potential or theoretical, not proven for SETP11 specifically)Genome regulation via RNA interference or ceRNA effects (observed in some pseudogenes, but not demonstrated for SETP11 specifically)
03

Disease associations

Other (no established disease roles for SETP11; some pseudogenes are implicated in cancer and other diseases, but this is not reported for SETP11)

Beyond the preview

Go deeper on SET pseudogene 11 (SETP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SET pseudogene 11 (SETP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call